Miniscule NCIBTORONTO , Aug. 28, 2023 /CNW/ - CareRx Corporation ("CareRx" or "the Company") (TSX: CRRX) today announced that its Board of Directors has authorized a normal course issuer bid (the "NCIB") to purchase for cancellation up to 1,000,000 of its common shares ("Shares"), representing approximately 1.73% of its 57,734,600 issued and outstanding Shares as at August 28, 2023. The NCIB is subject to the approval of the Toronto Stock Exchange (the "TSX").
Release does not specify the daily maximum allowable which is unusual.
Like do they care?